Nexstim Plc (NXTMH:HEX) ("Nexstim" or "Company") announces having received an NBS 5+ system order from the United States. The customer is acquiring the system for neuroscience use. The NBS 5+ system ...

Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company"), the targeted neuromodulation company developing and commercializing its world-leading navigated non-invasive brain stimulation technology ...

Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") announces that it has sold an NBT® System with SmartFocus® TMS technology at BrainStim Centers, United States. The system was first placed ...

Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") announces that an NBT® System with SmartFocus® TMS technology has been installed at Mind Matters PsychiatryMD in Texas, US. Mind Matters ...

Nexstim’s Therapy Business markets and sells the NBS System 6 which is FDA-cleared for marketing and commercial distribution for the treatment of major depressive disorder (MDD) in the United States.

Press release, Helsinki, 26 August 2019 at 9.30 am (EET) Achieve TMS, the second largest TMS group in the US, starts using Nexstim SmartFocus® TMS technology Nexstim Plc (NXTMH:HEX, NXTMS:STO) ...

Nexstim Oy ("Nexstim" or the "Company"), a medical technology company aiming to improve rehabilitation for stroke patients through the use of noninvasive brain stimulation, announces its support for ...

New Class of Navigated TMS Delivers Customized, Repeatable Treatments Improving Patient Care and Clinical Efficiencies Magstim, the global leader in neuroscience research and treatment for mental ...

Press Release, Helsinki, 4 February 2020 at 11.15 am (EET) Nexstim NBT® System with SmartFocus® TMS installed at Mind Matters PsychiatryMD, US Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company ...